MicroRNAs and their vital role in apoptosis in hepatocellular carcinoma : miRNA-based diagnostic and treatment methods
Copyright © 2023 Elsevier B.V. All rights reserved..
Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies with high invasive and metastatic capability. Although significant advances have been made in the treatment of HCC, the overall survival rate of patients is still low. It is essential to explore accurate biomarkers for early diagnosis and prognosis along with therapeutic procedures to increase the survival rate of these patients. Anticancer therapies can contribute to induce apoptosis for the elimination of cancerous cells. However, dysregulated apoptosis and proliferation signaling pathways lead to treatment resistance, a significant challenge in improving efficient therapies. MiRNAs, short non-coding RNAs, play crucial roles in the progression of HCC, which regulate gene expression through post-transcriptional inhibition and targeting mRNA degradation in cancers. Dysregulated expression of multiple miRNAs is associated with numerous biological processes, including cell proliferation, apoptosis, invasion and metastasis, epithelial-mesenchymal transition (EMT), angiogenesis, and drug resistance in HCC. This review summarizes the role and potential efficacy of miRNAs in promoting and inhibiting cell proliferation and apoptosis in HCC, as well as the role of miRNAs in therapy resistance in HCC.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:888 |
|---|---|
| Enthalten in: |
Gene - 888(2023) vom: 20. Dez., Seite 147803 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hajizadeh, Masoumeh [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Apoptosis |
|---|
| Anmerkungen: |
Date Completed 23.10.2023 Date Revised 23.10.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.gene.2023.147803 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362136777 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362136777 | ||
| 003 | DE-627 | ||
| 005 | 20231226090621.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.gene.2023.147803 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1207.xml |
| 035 | |a (DE-627)NLM362136777 | ||
| 035 | |a (NLM)37716587 | ||
| 035 | |a (PII)S0378-1119(23)00644-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hajizadeh, Masoumeh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a MicroRNAs and their vital role in apoptosis in hepatocellular carcinoma |b miRNA-based diagnostic and treatment methods |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.10.2023 | ||
| 500 | |a Date Revised 23.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Elsevier B.V. All rights reserved. | ||
| 520 | |a Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies with high invasive and metastatic capability. Although significant advances have been made in the treatment of HCC, the overall survival rate of patients is still low. It is essential to explore accurate biomarkers for early diagnosis and prognosis along with therapeutic procedures to increase the survival rate of these patients. Anticancer therapies can contribute to induce apoptosis for the elimination of cancerous cells. However, dysregulated apoptosis and proliferation signaling pathways lead to treatment resistance, a significant challenge in improving efficient therapies. MiRNAs, short non-coding RNAs, play crucial roles in the progression of HCC, which regulate gene expression through post-transcriptional inhibition and targeting mRNA degradation in cancers. Dysregulated expression of multiple miRNAs is associated with numerous biological processes, including cell proliferation, apoptosis, invasion and metastasis, epithelial-mesenchymal transition (EMT), angiogenesis, and drug resistance in HCC. This review summarizes the role and potential efficacy of miRNAs in promoting and inhibiting cell proliferation and apoptosis in HCC, as well as the role of miRNAs in therapy resistance in HCC | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Apoptosis | |
| 650 | 4 | |a Drug resistance | |
| 650 | 4 | |a Hepatocellular carcinoma | |
| 650 | 4 | |a Proliferation | |
| 650 | 4 | |a microRNA | |
| 650 | 7 | |a MicroRNAs |2 NLM | |
| 700 | 1 | |a Hajizadeh, Farnaz |e verfasserin |4 aut | |
| 700 | 1 | |a Ghaffarei, Sevil |e verfasserin |4 aut | |
| 700 | 1 | |a Amin Doustvandi, Mohammad |e verfasserin |4 aut | |
| 700 | 1 | |a Hajizadeh, Khadijeh |e verfasserin |4 aut | |
| 700 | 1 | |a Yaghoubi, Seyyed Mohammad |e verfasserin |4 aut | |
| 700 | 1 | |a Mohammadnejad, Fateme |e verfasserin |4 aut | |
| 700 | 1 | |a Khiabani, Nadia Allahyarzadeh |e verfasserin |4 aut | |
| 700 | 1 | |a Mousavi, Pegah |e verfasserin |4 aut | |
| 700 | 1 | |a Baradaran, Behzad |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Gene |d 1979 |g 888(2023) vom: 20. Dez., Seite 147803 |w (DE-627)NLM000233951 |x 1879-0038 |7 nnns |
| 773 | 1 | 8 | |g volume:888 |g year:2023 |g day:20 |g month:12 |g pages:147803 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.gene.2023.147803 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 888 |j 2023 |b 20 |c 12 |h 147803 | ||